Literature DB >> 12438380

Virulence criteria for Brucella abortus strains as determined by interferon regulatory factor 1-deficient mice.

Jinkyung Ko1, Annette Gendron-Fitzpatrick, Thomas A Ficht, Gary A Splitter.   

Abstract

Interferon regulatory factor 1-deficient (IRF-1(-/-)) mice infected with virulent Brucella abortus 2308 at 5 x 10(5) CFU developed acute hepatitis similar to many natural hosts but, unlike natural hosts, IRF-1(-/-) mice were unable to resolve infection and died. In contrast, IRF-1(-/-) mice survived when infected at 5 x 10(5) CFU with several attenuated Brucella strains (S19, RB51, cbp, and cyd). The survival of infected IRF-1(-/-) mice is likely a function of the level of virulence of each Brucella strain and the extent of retained immunity. Further, these findings suggest that adaptive immunity may be important to the survival of IRF-1(-/-) mice since attenuated Brucella strains can protect IRF-1(-/-) mice against lethal challenge with virulent Brucella: Using the IRF-1(-/-) mouse model, the following set of criteria were identified to define Brucella virulence: (i) the day of death for 50% of mice infected with 5 x 10(5)CFU of Brucella, (ii) the extent of liver toxicity, and (iii) the minimum immunizing dose of Brucella to protect against challenge with virulent S2308. Thus, IRF-1(-/-) mice are important to determining the level of Brucella virulence, to evaluating Brucella mutants for attenuation, and to investigating adaptive immunity in brucellosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438380      PMCID: PMC132959          DOI: 10.1128/IAI.70.12.7004-7012.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Interruption of the cydB locus in Brucella abortus attenuates intracellular survival and virulence in the mouse model of infection.

Authors:  S Endley; D McMurray; T A Ficht
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

2.  Ascites as the first manifestation of Brucella granulomatous hepatitis.

Authors:  E Caballeria; R M Masso; J V Arago; A Sanchis
Journal:  J Hepatol       Date:  1992-07       Impact factor: 25.083

3.  Brucella abortus tandem repeated ATP-binding proteins, BapA and BapB, homologs of haemophilus influenzae LktB, are not necessary for intracellular survival.

Authors:  J Ko; G A Splitter
Journal:  Microb Pathog       Date:  2000-10       Impact factor: 3.738

4.  Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice.

Authors:  J A Montaraz; A J Winter
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

5.  The effect of long-term ethanol feeding on Brucella melitensis infection of rats.

Authors:  Z Yumuk; S Ozdemirci; B F Erden; V Dundar
Journal:  Alcohol Alcohol       Date:  2001 Jul-Aug       Impact factor: 2.826

6.  Protection against the mortality associated with disease models mediated by TNF and IFN-gamma in mice lacking IFN regulatory factor-1.

Authors:  G Senaldi; C L Shaklee; J Guo; L Martin; T Boone; T W Mak; T R Ulich
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

7.  Brucella suis S2, brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice.

Authors:  N Bosseray; M Plommet
Journal:  Vaccine       Date:  1990-10       Impact factor: 3.641

8.  Susceptibility of IFN regulatory factor-1 and IFN consensus sequence binding protein-deficient mice to brucellosis.

Authors:  Jinkyung Ko; Annette Gendron-Fitzpatrick; Gary A Splitter
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

9.  Brucella abortus genes identified following constitutive growth and macrophage infection.

Authors:  L Eskra; A Canavessi; M Carey; G Splitter
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

10.  Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.

Authors:  T Matsuyama; T Kimura; M Kitagawa; K Pfeffer; T Kawakami; N Watanabe; T M Kündig; R Amakawa; K Kishihara; A Wakeham
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

View more
  19 in total

1.  Extended safety and efficacy studies of the attenuated Brucella vaccine candidates 16 M(Delta)vjbR and S19(Delta)vjbR in the immunocompromised IRF-1-/- mouse model.

Authors:  A M Arenas-Gamboa; A C Rice-Ficht; Y Fan; M M Kahl-McDonagh; T A Ficht
Journal:  Clin Vaccine Immunol       Date:  2011-12-14

2.  Attenuated bioluminescent Brucella melitensis mutants GR019 (virB4), GR024 (galE), and GR026 (BMEI1090-BMEI1091) confer protection in mice.

Authors:  Gireesh Rajashekara; David A Glover; Menachem Banai; David O'Callaghan; Gary A Splitter
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Mutant Brucella abortus membrane fusogenic protein induces protection against challenge infection in mice.

Authors:  Job Alves de Souza Filho; Vicente de Paulo Martins; Priscila Carneiro Campos; Juliana Alves-Silva; Nathalia V Santos; Fernanda Souza de Oliveira; Gustavo B Menezes; Vasco Azevedo; Silvio Lorenzo Cravero; Sergio Costa Oliveira
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

4.  Characterization and protective property of Brucella abortus cydC and looP mutants.

Authors:  Quang Lam Truong; Youngjae Cho; Abhijit Kashinath Barate; Suk Kim; Tae-Wook Hahn
Journal:  Clin Vaccine Immunol       Date:  2014-09-24

5.  Brucella melitensis cyclic di-GMP phosphodiesterase BpdA controls expression of flagellar genes.

Authors:  Erik Petersen; Pallab Chaudhuri; Chris Gourley; Jerome Harms; Gary Splitter
Journal:  J Bacteriol       Date:  2011-08-19       Impact factor: 3.490

6.  Decreased in vivo virulence and altered gene expression by a Brucella melitensis light-sensing histidine kinase mutant.

Authors:  Christopher R Gourley; Erik Petersen; Jerome Harms; Gary Splitter
Journal:  Pathog Dis       Date:  2015-02-26       Impact factor: 3.166

7.  The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice.

Authors:  Cyntia G M C Trant; Thais L S Lacerda; Natalia B Carvalho; Vasco Azevedo; Gracia M S Rosinha; Suzana P Salcedo; Jean-Pierre Gorvel; Sergio C Oliveira
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

8.  Brucella melitensis, B. neotomae and B. ovis elicit common and distinctive macrophage defense transcriptional responses.

Authors:  Jill Covert; Angela J Mathison; Linda Eskra; Menachem Banai; Gary Splitter
Journal:  Exp Biol Med (Maywood)       Date:  2009-12

9.  Nondividing but metabolically active gamma-irradiated Brucella melitensis is protective against virulent B. melitensis challenge in mice.

Authors:  D M Magnani; J S Harms; M A Durward; G A Splitter
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

10.  Denitrification genes regulate Brucella virulence in mice.

Authors:  Seung-Hun Baek; Gireesh Rajashekara; Gary A Splitter; James P Shapleigh
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.